Pricing Log in Create free account
Saturday 17 October 2026 Export REGN’s income statement to Excel — free account

Regeneron Pharmaceuticals, Inc.

REGN Healthcare Biotechnology

Regeneron Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, up 0.99% from fiscal 2024. In the quarter to June 2026, revenue grew 16.7%, EPS fell 4.68%, free cash flow fell 29.3% and total debt fell 26.6%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for three consecutive years.

790.74 5.60 −0.70%
Market cap
$82.0B
P/E
18.9×
Fwd P/E
16.5×
Dividend yield
0.47%
F-score
5/9
Altman Z
7.49
Beneish M
−2.53
Dividend safety
77/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Regeneron Pharmaceuticals, Inc. (REGN) Book value per share

Alert me on Book value per share

Regeneron Pharmaceuticals, Inc.'s book value per share at the end of fiscal 2025 was 299×, up 9.84% from 272× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 308×. Over the past ten years it has ranged from 35.5× (fiscal 2015) to 299× (fiscal 2025) — the current reading is the highest in ten years. Regeneron Pharmaceuticals, Inc. ranks 3rd of 612 Biotechnology companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 299× 9.84%
FY2024 272× 11.76%
FY2023 243× 15.03%
FY2022 212× 19.18%
FY2021 178× 73.29%
FY2020 102× 0.90%
FY2019 102× 25.13%
FY2018 81.2× 40.42%
FY2017 57.8× 36.01%
FY2016 42.5× 19.83%

Quarterly newest first

Period Book value per share Change
Jun 2026 308× 2.09%
Mar 2026 302× 1.11%
Dec 2025 299× 0.00%
Sep 2025 299× 4.90%
42 more quarters

Against its own ten years

Low 35.5× High 299×
Ten-year median 102×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
REGN Regeneron Pharmaceuticals, Inc. 308×
ARGX argenex SE compare 135×
VRTX Vertex Pharmaceuticals Incorporated compare 79.8×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 46.4×
RPRX Royalty Pharma PLC compare 22.0×
MRNA Moderna, Inc. compare 17.0×
RVMD Revolution Medicines, Inc. compare 12.4×
ALNY Alnylam Pharmaceuticals, Inc. compare 10.1×
ROIV Roivant Sciences Ltd. compare 6.8×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on REGN